Camilla Göktürk Selected Research

SCH 51344

4/2014

Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Camilla Göktürk Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 04/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2021
1	Genomic Instability 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 11/2021
1	Carcinoma (Carcinomatosis) 04/2014
1	Alcoholism (Alcohol Abuse) 12/2009
1	Antisocial Personality Disorder (Antisocial Personality) 12/2009
1	Insulin Resistance 09/2009

Drug/Important Bio-Agent (IBA)

3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 04/2014
3	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 04/2014
2	NucleotidesIBA 11/2021 - 04/2014
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Methylenetetrahydrofolate Dehydrogenase (NADP) (Dehydrogenase, Methylenetetrahydrofolate)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	EnzymesIBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	ThymidineIBA 01/2022
1	karonudibIBA 11/2021
1	Small Interfering RNA (siRNA)IBA 12/2020
1	SCH 51344IBA 04/2014
1	CrizotinibIBA 04/2014
1	Serotonin (5 Hydroxytryptamine)IBA 12/2009
1	Transcription Factor AP-2IBA 12/2009
1	LipidsIBA 09/2009
1	Insulin (Novolin)FDA Link 09/2009
1	Glucose (Dextrose)FDA LinkGeneric 09/2009
1	Transcription Factors (Transcription Factor)IBA 09/2009
1	AdiponectinIBA 09/2009